Products

1229194-11-9, i.e., edoxaban p-toluenesulfonate monohydrate, is a compound with important biological activity. It is an orally administered direct factor Xa selective inhibitor, mainly used as an anticoagulant for the prevention of stroke and the treatment of thromboembolic disease.

Methylene blue was first synthesized in 1876 by zinc chloride salt.

Indolebufen is an antiplatelet aggregation drug, which can selectively act on circulating platelets, block thrombosis, inhibit the release of platelet factors and exert antiplatelet aggregation effect, this inhibition is reversible, does not change plasma parameters, does not affect platelet function, and normalizes abnormal platelet function. It can significantly improve the microcirculatory parameters and walking distance in patients with peripheral vascular lesions and intermittent claudication, and prevent obstruction after coronary artery shunt and femoral shunt, which is comparable to that of aspirin plus dipyridine; During hemodialysis, it can significantly reduce platelet deposits on the dialysis membrane, and this product can also prevent secondary thrombosis after a transient ischemic attack or mild stroke. Compared with similar drugs, indolebufen inhibits platelet factors, and the anti-platelet aggregation effect is 2~5 times that of salicylic acid, and it has a shorter bleeding time than a slight duration. There was no significant difference in oral efficacy compared with ticlopidine, but indobufen was well tolerated.

Triprolidine hydrochloride monohydrate (CAS number: 6138-79-0) is an orally active histamine H1 antagonist.

Relugolix (CAS number: 737789-87-6), also known as relugolis or TAK-385, is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist jointly developed by Myovant and Takeda. 

The compound with the CAS number 3505-38-2 is Carbinoxamine Maleate, also known as Carbinoxamine Tartrate. It is a mildly sedating antihistamine with significant sedative and anticholinergic effects, while having a lower risk of gastrointestinal side effects. 

The compound with the CAS number 61718-82-9 is Fluvoxamine Maleate, which is a selective serotonin reuptake inhibitor (SSRI) mainly used to treat depression, obsessive-compulsive disorder, and related anxiety symptoms.

Tedizolid phosphate, also known as tedizolid phosphate, tedizolid phosphate, tedizolid phosphate is a second-generation oxazolidinone antibiotic developed by Dong-APharmaceutical, and its phase III clinical trial showed that its clinical effect was comparable to linezolid.

The compound with CAS number 204255-11-8 is 5-azide oseltamivir, also known as (3R,4R,5S)-4-(acetamino)-5-azide-3-(1-ethylpropoxy)-1-cyclohexen-1-carboxylate ethyl ester, which is a key intermediate in the synthesis of oseltamivir. Oseltamivir is a neuraminidase inhibitor that is mainly used to treat and prevent influenza A and B.

5104-49-4 is the CAS number for flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and anti-inflammatory effects. The chemical name of flurbiprofen is 2-fluoro-α-methyl(1,1'-diphenyl)-4-acetic acid, the molecular formula is C15H13FO2, and the molecular weight is 244.26. It is mainly used in clinical practice for the treatment of rheumatoid arthritis, osteoarthritis, post-operative pain, and pain relief for various cancers.

Fimarsartan (CAS number: 247257-48-3) is a novel non-peptide angiotensin II receptor antagonist (ARB) mainly used for the treatment of hypertension and heart failure.

Dotinurad (CAS number: 1285572-51-1) is a urate reabsorption inhibitor for the treatment of hyperuricemia and gout. It increases uric acid excretion and lowers blood uric acid levels by inhibiting the uric acid transporter URAT1 in the kidneys, thereby increasing uric acid excretion.